502 Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028. (September 2015) - O'Neil, B.H.; Wallmark, J.; Lorente, D.; Elez, E.; Raimbourg, J.; Gomez-Roca, C.; Ejadi, S.; Piha-Paul, S.A.; Moss, R.A.; Siu, L.L.; Dotti, K.; Santoro, A.; et al.